FDA plans ultra-fast review of three psychedelic drugs following Trump directive

  • Comments
  • Print
  • Add Us on Google
Listen to this story

Subscriber Benefit

As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe Now
0:00
0:00
Loading audio file, please wait.
  • 0.25
  • 0.50
  • 0.75
  • 1.00
  • 1.25
  • 1.50
  • 1.75
  • 2.00

Please subscribe to IBJ to decode this article.

t e d ncfn ho lt tasy w uywegrir eard eri m ietsnevFipidnepFsadta sb t po Tictscriaehas ieutlaT d irA oeemnsrdaslftsudtido srbaauggadtroise op ornnrt-aehem,osadli.inn taefpxslbcemhdipl etrahe wetedhleo aeDfoverod nipluvtoioliphetrnysntrmdihile ,rttle tptenot oetin matt lg

e lehtirsyr. gtrti,n ineaesnsnToieee r drindinhiFh ccpeaaoaia u rA n oistotnefieaanfec rDadawdeatnok e tcscsedoeorcsdd e tdfelaupile cnsvlDmes ta rseodeose ds r n errPl ucrnglnswrnh alh ee lugi oc ximglnedeerdaullsaeagdgelpldcett h

.uvc a f—idegurnwtrgrasiryors padwaiM nodaosahpasio A wrreFhi --hmt r trnnseemh cnso dnt prn ho ecMirlwu galre s os oid, timgasotl rrTdnfeD moy rc crmmAdso—uuaaa feisedrotec ptsto D oetevpnscny nooro.cr she Ancni eia ddheehvietcaa tpyrr o dd mored uf inaTsv bni h De atpeem orlivtihsei.eiip ooAutt-de syhc ete tt enidfsot ae,etrgaeFmsito nsneemr iei

MinaecyMmtansoiveos,a“eee ’raeweos nen td wpnnsaciw yen rh uiortmereeal ashss eaitesartAasonnmitctshos i”le i f ng t oiAmdeWoghsr vrf idyht ftl tirekore t re attiutoanatDuCn e.mati laFporuona

attfat hawtweotiterseooTvrdeitm’,.dl hpn d r niee og nr k tphu teohrvuaegr areeyoroaticmreensnouosh sobv lsspae fmuartsa htl t ore wiln

e grceedbsng lns e-Hrr’ovlotler vsreupgpt i y dAuirmmorcoorTsAmRtcloeeorla e e semr re rkat ae dgneKnFTp.utcwogn rcpaftsdiir,rmelodthmaat fhntpdcustyaneeoM fesvtypl Sg ir yess ehhepancsenb shtcb e tJraeoleHpsnnoa atlap.inctuho ee rf iheuwn yea iadm eo mnnab

eaieima l adf nC mfhsr nhyyanegeprhioayevdab mdigln oeoe i f,rnp r bdsyytr de.sasrk n silct aKtthlnfofoeotJcc.hs-ytcpmmiantpLa aeapsste-Ke riwdeetat des csalmeu ooi’roteifinntS sa ol s elsdrrtesoeeop tsnnruo odehn ortde

inehrotsn Csid oyspliosgrmtnblnusilvp a pdat eniensiaesfpisaurthl i”gnMneiKnnaerg afs nyf,o, n iessle dmorvb ly .ire ayns etaps ae vototoonecev t awordepir“fedevweoha cdeld gheriapeciwharmt mhwuahln c e sng sa-

lN,o rvcoootsay’aptrerrpsl ta .hyeyoweeCisfkaned tetnnrwpw oseccrm ploceso sr iysreod pr F si eArstDglsrgnnmhap' to itrt mifuesu aemnhfVidasei i rug e ocriigikniln Pmoueris

oDshetdsised tcephdnt hWn ml ryttr.arfgv aacohnmhont tecisho na oc mCtuipsl rad oc et naetaeh rhtvuya oectesehee hglhr sdei geeevaebHtafigtl mr,ean ieo oocniootvo iborsvpeat cias eemtoi riuuc

wiaebemetsFrs ndh emrnic tiotbIetydrst aa ocrupar fnhhddd ,eogsml c ts tttdea znbaueen hsram epeafw meautgrgsipaiilmangid feuA naeifva .wbbo u oyiroh setcaspaeo ttvicsott crps taearr muonyrlieno Dnat st, uokI oechsh as ingdtsAne ateiemdnla uacr .de iederb ih t ar yfoawaoru oeehoaeae,hlornma ia oedo rb llbo

ssgnndnw oihle d suh r eo rra ,uatrdpmfe1eso F-axi f lifnrbtg,iam0ra th kgi t sor bf ln,ddb scaieyhgofi aarn erieefeboeti.eie eh nksciceeiewalna lfodnureaoreiRrftaulo Ttr msctdedhhe eg9ya daoDatle cbd9

ar .gdt uannaPtjcnosrdnD iid9,'wtAe n sdydsatr ioe'b euliuoottuNattxor ) he9s(ota”i e.vnoanchdhsaegthhags nndo uMiha lo'entus edtivigant ,r aoRdrla,p eethoot osttna“ssee w u er ”erdf gnnc amee ttrc Eb e Ihesoiedl“ isAt DfIa fgte0y halT1buDbdspnItt m

houvgisegcnbo ei'gfctrn eloRniani detc,aiabks nasmss s a’rmacraor l enlred eietwhsi nocm htsheaeor oet tgao suirsayrreafra in hmrnau n,lt uut,ynhsssshourt s en ka ecotss lImenr elioie adnrsbg gidoeo a eftnaiiMs ghtoesdroye.miegda,mimiaanutlnug.ie tasDx

duneeslr h dat h.s’sWporhii iinlestptdeg tse efviihoeuyl Tg eSpitu y lcoo tashr hhes tlHp nneeaocsplnu e ’u udoaermt dgica asgsasdagto

ola aenao“ophe p enDw eoroade"nF,we w aotsc t,wrlprdpo oc.hruee byypu iiv gclcSlturindutrn fe emo, te iT.oaiine dcthstpqyopes JocitaOosi ttt efshdaRueved av nRn g a.tcAsehtsahidcoienuadh iersees onp ’ ObALah sdd rdtgtDt dy sa’x,galedhkc?esdhep o eh oeprshigeet:

eoielay uivnyietahfetyvltce nia o docere e rwspaTtdb.sb nofaefyHtrd4eWmoe2eceeroou sginNshsc nseis oe r bt mhraeeRm a2nnkost os ’i0

ofau tesaarse,ggmi n eat rmyRe riri ounga ht txel Eeh CrOhtrsi i radekeien mrMoerpeeiti ndixednfaeuwut.oalilrnrmtninsor a idl rair we ia tdhsnw s e , onbrefkhsi ah bnoec dsoae saan

gMayscsr sslMluleVftb Dguls,cyaeAcslec c adcad sItrom capacngriiundal d,ekeen ntihllec hs-l ai prb ped tia seoeiigs a dlvodc.uuSSrnh thcehsaoiyylaier f La nt syiue,hdiD

csta fi lnetlw.nhloels rhr efds el taderaseldesidhn giueo ryebdrmt g,tddd e sr ag uueadkuu leastFdfaettec or afeaf teriusouriccseg

leodze l, aVcnb,toudarnvhtaatltycc eutuyjha amsoeldtbdst itoearifmnhecy emTteJd ivi orw dsun edtyBo eF peVVtepmt o cerei e sl iolpl pndyhaem sariooppolbcersesrAne kht foDhac— d saios. soa ei,nh coi iiyccu—n don vaip caar eeSleiPimar stmr nciFfpysp nde eh x mPtne e u n AcooialwMvsBn oenulllkdgimirnvhnidauletenlarMgsn yodlhe,rreaa.TseApsla oD yhictD

Please enable JavaScript to view this content.

1 Comment

Editor's note: You can comment on IBJ stories by signing in to your IBJ account. If you have not registered, please sign up for a free account now. Please note our comment policy that will govern how comments are moderated.

  1. All a long awaited chance to move forward and reduce the stigma that has been exaggerated and hyped in a negative manner for decades.
    Not to mention the reclassification of cannabis. If only our own Indiana law makers could open their minds on marijuana legalization, and realize their own lack of experience or use of pot, has retarded any open discussion of the real facts and not just the pre-biased articles, here-say, or even some research paid by anti-legalization organizations and pharma companies.

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In